Woburn, MA — CryoXtract Instruments, LLC, a leader in developing unique automation solutions for preserving and optimizing frozen biological samples, reached a non-exclusive global co-marketing agreement with Wheaton Industries, Inc. that will provide the worldwide scientific community with a unique set of solutions for optimally storing, preserving and accessing valuable frozen tissue samples.

CryoXtract recently introduced its second commercial product, the CXT 350, to provide the scientific community multiple access to valuable frozen tissue samples while preserving the frozen state of both the parent sample and cored aliquots throughout the process. This unique solution allows multiple access to highly valuable frozen tissue samples while preserving the integrity of the parent biospecimen, thereby resulting in optimized sample usage and higher quality scientific outcomes.

About CryoXtract Instruments, LLC

CryoXtract develops and commercializes unique automation solutions that allow for the retrieval of multiple frozen biosamples from a single sample without exposing the source to the deleterious biological impact of freeze/thaw cycling. The Company’s novel automation technology platform improves frozen biosample processing, protects the viability of frozen biosamples after cores have been extracted, improves lab efficiencies and economics, and results in improved scientific outcomes. In May 2012, the International Society for Biological and Environmental Biorepositories (ISBER) awarded its prestigious Outstanding New Product Award to the Company’s CXT 750 Frozen Sample Aliquotter.

About Allied Minds, Inc.

CryoXtract is a subsidiary of Allied Minds, Inc., a Boston-based private investment corporation. For more information, please visit https://www.cryoxtract.com/.

For more information:

For media inquiries about CryoXtract and Allied Minds: Christine Dunn, Savoir Media, cdunn@savoirmedia.com or 617.484.1660, x101.

For corporate inquiries: John A. McCarthy, Jr., john.mccarthy@cryoxtract.com